|
ADC Clinical Trials
2 actively recruiting trials across 1 location
Pipeline
Phase 2: 1Phase 1/2: 1
Top Sponsors
- MBrace Therapeutics1
- Fudan University1
Indications
- Breast Cancer2
- Cancer2
- Pancreas Cancer, Duct Cell Adenocarcinoma1
- Lung Cancer - Non Small Cell1
- Prostate Cancer Castration-resistant Prostate Cancer1
Other1 trial
San Francisco, California1 trial
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
UCSF Helen Diller Family Comprehensive Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.